Post-COVID Interstitial Lung Disease-The Tip of the Iceberg

Namrata Kewalramani, Kerri-Marie Heenan, Denise McKeegan, Nazia Chaudhuri

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)
3 Downloads (Pure)


The proportion of symptomatic patients with post-coronavirus 2019 (COVID-19) condition (long COVID) represents a significant burden on the individual as well as on the health care systems. A greater understanding of the natural evolution of symptoms over a longer period and the impacts of interventions will improve our understanding of the long-term impacts of the COVID-19 disease. This review will discuss the emerging evidence for the development of post-COVID interstitial lung disease focusing on the pathophysiological mechanisms, incidence, diagnosis, and impact of this potentially new and emerging respiratory disease. [Abstract copyright: Copyright © 2023 Elsevier Inc. All rights reserved.]
Original languageEnglish
Pages (from-to)389-410
Number of pages22
JournalImmunology and allergy clinics of North America
Issue number2
Early online date3 Mar 2023
Publication statusPublished (in print/issue) - 31 May 2023

Bibliographical note

Funding Information:
N. Kewalramani reports grant and nonfinancial support from CSL Behring, Bern (Switzerland) outside the submitted work. K.-M. Heenan has nothing to disclose. D. McKeegan has nothing to disclose. N. Chaudhuri has nothing to disclose.


  • Humans
  • COVID-19
  • Post-Acute COVID-19 Syndrome
  • Respiration Disorders
  • Lung Diseases, Interstitial - diagnosis - epidemiology - etiology
  • SARS-CoV-2
  • Interstitial lung disease
  • Long-term impact
  • Post-COVID fibrosis
  • Post-COVID-19 condition (long COVID)


Dive into the research topics of 'Post-COVID Interstitial Lung Disease-The Tip of the Iceberg'. Together they form a unique fingerprint.

Cite this